346 related articles for article (PubMed ID: 11490804)
1. A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection.
Hsieh YH; Lin HJ; Tseng GY; Perng CL; Chang FY; Lee SD
Hepatogastroenterology; 2001; 48(40):1078-81. PubMed ID: 11490804
[TBL] [Abstract][Full Text] [Related]
2. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
3. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
4. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
Hsu CC; Lu SN; Changchien CS
Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori.
Chu KM; Choi HK; Tuen HH; Law SY; Branicki FJ; Wong J
Am J Gastroenterol; 1998 Sep; 93(9):1436-42. PubMed ID: 9732921
[TBL] [Abstract][Full Text] [Related]
7. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
Annibale B; D'Ambra G; Luzzi I; Marcheggiano A; Iannoni C; Paoletti M; Anania MC; Marignani M; Delle Fave G
Am J Gastroenterol; 1997 May; 92(5):790-4. PubMed ID: 9149186
[TBL] [Abstract][Full Text] [Related]
8. Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
Calvet X; García N; Campo R; Brullet E; Comet R; Navarro M
Am J Gastroenterol; 1998 Jun; 93(6):932-4. PubMed ID: 9647022
[TBL] [Abstract][Full Text] [Related]
9. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
11. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
12. [Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori].
Flores S; Opazo H; Valderrama D; Aguilera R; Marchese A; Valderrama S
Rev Med Chil; 2000 May; 128(5):509-12. PubMed ID: 11008354
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
[TBL] [Abstract][Full Text] [Related]
15. The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Horvat D; Vcev A; Soldo I; Timarac J; Dmitrović B; Misević T; Ivezić Z; Kraljik N
Coll Antropol; 2005 Jun; 29(1):139-42. PubMed ID: 16117312
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease.
Vcev A; Vceva A; Takac B; Dmitrović B; Stimac D; Stimac T; Kovac D; Pezerović D; Blazanović A; Ivandić A; Karner I
Acta Med Croatica; 1998; 52(4-5):209-14. PubMed ID: 9988898
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
Lai KC; Hui WM; Wong WM; Wong BC; Hu WH; Ching CK; Lam SK
Am J Gastroenterol; 2000 Sep; 95(9):2225-32. PubMed ID: 11007222
[TBL] [Abstract][Full Text] [Related]
18. A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Yang JC; Yang KC; Hsu CT; Wang CS; Kuo CF; Wang TH
J Microbiol Immunol Infect; 1999 Mar; 32(1):1-8. PubMed ID: 11561564
[TBL] [Abstract][Full Text] [Related]
19. Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?
Lin HJ; Tseng GY; Hsieh YH; Perng CL; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 1999 Nov; 94(11):3184-8. PubMed ID: 10566712
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
